Status:

UNKNOWN

Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19)

Lead Sponsor:

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Collaborating Sponsors:

Instituto de Salud Carlos III

Conditions:

COVID-19

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

COVID-19 is a respiratory disease caused by the new coronavirus (SARS-CoV-2) and causes considerable morbidity and mortality. Currently, there is no vaccine or therapeutic agent to prevent and treat ...

Eligibility Criteria

Inclusion

  • Subject (or authorized legal representative) who can provide written informed consent before beginning any study procedure.
  • Understand and agree to abide by the study procedures.
  • Adult #18 years of age at the time of inclusion in the study.
  • Confirmation of SARS-CoV-2 infection by a microbiological test performed before randomization, no longer than 72 hours.
  • Severity 3-4 according to the WHO 7-point ordinal scale.

Exclusion

  • ALT / AST\> 5 times the normal limit
  • Stage 4 chronic kidney disease (GFR \<30) or requiring dialysis.
  • Presence of comorbidities that imply a poor prognosis (according to clinical judgment).
  • Advanced dementia.
  • Pregnancy or breastfeeding.
  • Anticipation of transfer to another center in the 12 hours at the beginning of the study.
  • Allergy to study medication.
  • Serious or active bacterial infections or documented sepsis by pathogens other than SARS-CoV-2.
  • Streptococcus pneumoniae antigenuria positive before study start.
  • Neutropenia \<500 / mm3.
  • Thrombocytopenia \<100,000 / mm3.
  • History of diverticulosis.
  • Ongoing skin infection (eg, pyodermitis).
  • Transplanted patient under immunosuppressive treatment.
  • Previous evidence of latent untreated tuberculosis.

Key Trial Info

Start Date :

April 2 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2021

Estimated Enrollment :

276 Patients enrolled

Trial Details

Trial ID

NCT04332094

Start Date

April 2 2020

End Date

July 1 2021

Last Update

May 6 2021

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Hospital Universitario Central de Asturias

Oviedo, Principality of Asturias, Spain

2

Hospital General Universitario de Alicante

Alicante, Valencia, Spain

3

Hospital General Universitario de Elche

Elche, Valencia, Spain

4

Hospital de la Santa Creu i Sant Pau

Barcelona, Spain